GlassScriptPhysician profile
Samin Sharma
NPI 1376572933
$290,912.31
in general payments reported to CMS, 2019-2025
20 companies · $21K in 2025
The $21K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $35K · 2021: $30K · 2022: $68K · 2023: $49K · 2024: $41K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $90K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $18K · Food and Beverage: $2,146 · Travel and Lodging: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $90,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $18,000.00 |
| Food and Beverage | $2,145.84 |
| Travel and Lodging | $1,050.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $207,092.94 | 2019-2025 | General - Atherectomy, Vitalyst, Varithena Administration Pack |
| Medtronic, INC. | $33,315.19 | 2021-2024 | Corevalve Evolut R, Hawkone, In.Pact Av |
| Cardiovascular Systems INC. | $19,313.74 | 2019-2022 | |
| Medtronic Vascular, INC. | $15,419.88 | 2019-2020 | |
| Abbott Laboratories | $15,203.86 | 2019-2025 | Mitraclip, Navitor, Pressurewire |
| Edwards Lifesciences Corporation | $145.17 | 2024 | Pascal, Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $119.65 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bracco Diagnostics INC. | $77.43 | 2024 | |
| Novo Nordisk INC | $71.58 | 2024 | Ozempic |
| Acist Medical Systems, INC. | $34.91 | 2024 | |
| Recor Medical INC | $27.09 | 2025 | Paradise Ultrasound Renal Denervation System |
| Abiomed | $26.99 | 2023 | Impella |
| Cardiva Medical, INC. | $24.13 | 2025 | Savvywire |
| Novartis Pharmaceuticals Corporation | $22.91 | 2024 | |
| Amgen INC. | $16.84 | 2025 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samin Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.